Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 1.760
0.00 (0.00%)
At close: Feb 10, 2026
Vitrafy Life Sciences Revenue
Vitrafy Life Sciences had revenue of 1.98M AUD in the half year ending December 31, 2025, with 64.59% growth. This brings the company's revenue in the last twelve months to 2.34M, up 51.87% year-over-year. In the fiscal year ending June 30, 2025, Vitrafy Life Sciences had annual revenue of 1.05M, down -49.14%.
Revenue (ttm)
2.34M
Revenue Growth
+51.87%
P/S Ratio
47.96
Revenue / Employee
n/a
Employees
22
Market Cap
112.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.05M | -1.01M | -49.14% |
| Jun 30, 2024 | 2.06M | 3.53K | 0.17% |
| Jun 30, 2023 | 2.06M | 230.64K | 12.63% |
| Jun 30, 2022 | 1.83M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition